{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T08:37:58Z","timestamp":1767688678807,"version":"3.48.0"},"reference-count":24,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"unspecified","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001009","name":"Bristol Myers Squibb Foundation","doi-asserted-by":"publisher","award":["grant ID 54124635"],"award-info":[{"award-number":["grant ID 54124635"]}],"id":[{"id":"10.13039\/100001009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Qual"],"accepted":{"date-parts":[[2025,12,5]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Anticoagulation for stroke prevention is often recommended for patients with non-valvular atrial fibrillation (AF), yet many eligible patients do not receive guideline-concordant anticoagulation. Prior quality improvement (QI) initiatives to improve anticoagulation in AF have had mixed results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Preventing Preventable Strokes: Scalability used a triad of interventions to increase the number of eligible patients with AF receiving guideline-concordant anticoagulation, including (1) a best practice alert integrated with the electronic health record, (2) clinician education and (3) patient communication about the anticoagulation therapy that encouraged shared decision-making with clinicians. These interventions were conducted in primary care and cardiology outpatient clinics at (University of Florida Health). Patient-level data were collected during a 6-month intervention period and compared with a 6-month historical control period. Generalised estimating equations with a logistic link were used to estimate the odds of anticoagulant use, adjusting for demographic and clinical characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 3274 individuals were included during the intervention period and 3200 during the preintervention period. The average anticoagulation rate increased from 75.7% to 79.2% across the two periods. In the fully adjusted model, patients in the intervention period had significantly higher odds of anticoagulant use compared with the preintervention period (adjusted OR (aOR) 1.13, 95%\u2009CI 1.05 to 1.21, p=0.0007). MyChart activation (aOR 1.38, 95%\u2009CI 1.19 to 1.61, p&lt;0.0001) was also associated with increased anticoagulant use. Older age and higher CHA\n                      <jats:sub>2<\/jats:sub>\n                      DS\n                      <jats:sub>2<\/jats:sub>\n                      -VASc scores were associated with greater odds of anticoagulant use, while higher HAS-BLED scores and care in primary care (rather than cardiology) were associated with lower odds.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A triad of QI interventions at the practice, clinician and patient levels increased guideline-concordant anticoagulation use among patients with AF in half of the primary care and cardiology clinics in the University of Florida Health system.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjoq-2025-003311","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T08:35:27Z","timestamp":1767688527000},"page":"e003311","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Enhancing adherence to guideline-directed use of anticoagulant therapy in atrial fibrillation: a triad of quality improvement interventions in an academic outpatient setting"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8703-7337","authenticated-orcid":false,"given":"Kun","family":"Xiang","sequence":"first","affiliation":[{"name":"College of Medicine Department of Medicine Cardiology Division, University of Florida Health, Gainesville, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asinamai M","family":"Ndai","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Florida Health, Gainesville, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Reise","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Florida Health, Gainesville, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5396-0422","authenticated-orcid":false,"given":"Eric I","family":"Rosenberg","sequence":"additional","affiliation":[{"name":"College of Medicine Department of Internal Medicine, University of Florida Health, Gainesville, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John N","family":"Catanzaro","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, East Carolina University, Greenville, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Marie","family":"Smith","sequence":"additional","affiliation":[{"name":"Quality Improvement, Heart Rhythm Society, Washington, District of Columbia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Moore","sequence":"additional","affiliation":[{"name":"Quality Improvement, Heart Rhythm Society, Washington, District of Columbia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ted","family":"Singer","sequence":"additional","affiliation":[{"name":"PeerView Institute for Medical Education, PeerView Institute, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4465-974X","authenticated-orcid":false,"given":"Margery","family":"Tamas","sequence":"additional","affiliation":[{"name":"PeerView Institute for Medical Education, PeerView Institute, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia","family":"Jackson","sequence":"additional","affiliation":[{"name":"CME by Design, Santee, South Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Dietrich","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Florida Health, Gainesville, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie","family":"Conti","sequence":"additional","affiliation":[{"name":"College of Medicine Department of Medicine, University of Florida Health, Gainesville, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marvin","family":"Dewar","sequence":"additional","affiliation":[{"name":"College of Medicine UF Health Physicians, University of Florida Health, Gainesville, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"2026010600351986000_15.1.e003311.1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","article-title":"50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study","volume":"386","author":"Schnabel","year":"2015","journal-title":"The Lancet"},{"key":"2026010600351986000_15.1.e003311.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2013.05.063"},{"key":"2026010600351986000_15.1.e003311.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.10.062"},{"key":"2026010600351986000_15.1.e003311.4","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.22.8.983"},{"key":"2026010600351986000_15.1.e003311.5","doi-asserted-by":"crossref","first-page":"66A","DOI":"10.1378\/chest.2250462","article-title":"Treatment and Discharge Patterns Among Patients Hospitalized With Nonvalvular Atrial Fibrillation (NVAF) Who Transition From the Inpatient to Outpatient Setting","volume":"148","author":"Trocio","year":"2015","journal-title":"Chest"},{"key":"2026010600351986000_15.1.e003311.6","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000665"},{"key":"2026010600351986000_15.1.e003311.7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz278"},{"key":"2026010600351986000_15.1.e003311.8","unstructured":"Joglar JA , Chung MK , Armbruster AL , et al . ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation. 2023."},{"key":"2026010600351986000_15.1.e003311.9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.14503\/THIJ-16-5785","article-title":"Underuse of Oral Anticoagulants for Nonvalvular Atrial Fibrillation: Past, Present, and Future","volume":"43","author":"Wehbe","year":"2016","journal-title":"Tex Heart Inst J"},{"key":"2026010600351986000_15.1.e003311.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2009.11.025"},{"key":"2026010600351986000_15.1.e003311.11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/17482941.2017.1406954","article-title":"A multi-hospital analysis of predictors of oral anticoagulation prescriptions for patients with actionable atrial fibrillation who attend the emergency department","volume":"18","author":"Scott-Herridge","year":"2016","journal-title":"Acute Card Care"},{"key":"2026010600351986000_15.1.e003311.12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jamacardio.2015.0374","article-title":"Oral Anticoagulant Therapy Prescription in Patients With Atrial Fibrillation Across the Spectrum of Stroke Risk: Insights From the NCDR PINNACLE Registry","volume":"1","author":"Hsu","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2026010600351986000_15.1.e003311.13","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.119.005871","article-title":"SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation: A Cluster-Randomized Study of Electronic Profiling and Messaging Combined With Academic Detailing for Providers Making Decisions About Anticoagulation in Patients With Atrial Fibrillation","volume":"13","author":"Kapoor","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026010600351986000_15.1.e003311.14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ahj.2022.01.013","article-title":"The ENHANCE-AF clinical trial to evaluate an atrial fibrillation shared decision-making pathway: Rationale and study design","volume":"247","author":"Baykaner","year":"2022","journal-title":"Am Heart J"},{"key":"2026010600351986000_15.1.e003311.15","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028562","article-title":"Randomized Clinical Trial to Evaluate an Atrial Fibrillation Stroke Prevention Shared Decision-Making Pathway","volume":"12","author":"Wang","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2026010600351986000_15.1.e003311.16","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.cjca.2019.03.020","article-title":"Home-Based Education and Learning Program for Atrial Fibrillation: Rationale and Design of the HELP-AF Study","volume":"35","author":"Hendriks","year":"2019","journal-title":"Canadian Journal of Cardiology"},{"key":"2026010600351986000_15.1.e003311.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2019.08.007"},{"key":"2026010600351986000_15.1.e003311.18","doi-asserted-by":"crossref","unstructured":"Xiang K , McManus D , Catalano C , et al . Abstract 6905: Implementing, Launching and Sustaining a Quality Improvement Initiative in the Era of COVID-19: Challenges and Successes. Circulation 2021;144. doi:10.1161\/circ.144.suppl_1.6905","DOI":"10.1161\/circ.144.suppl_1.6905"},{"key":"2026010600351986000_15.1.e003311.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.03.540"},{"key":"2026010600351986000_15.1.e003311.20","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s11239-021-02420-8","article-title":"SUPPORT-AF III: supporting use of AC through provider prompting about oral anticoagulation therapy for AF","volume":"52","author":"Sadiq","year":"2021","journal-title":"J Thromb Thrombolysis"},{"key":"2026010600351986000_15.1.e003311.21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cvdhj.2021.06.001","article-title":"SUPPORT-AF IV: Supporting use of AC through provider prompting about oral anticoagulation therapy for AF clinical trial study protocol","volume":"2","author":"Patel","year":"2021","journal-title":"Cardiovasc Digit Health J"},{"key":"2026010600351986000_15.1.e003311.22","doi-asserted-by":"publisher","DOI":"10.4997\/JRCPE.2020.309"},{"key":"2026010600351986000_15.1.e003311.23","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.hrthm.2023.02.008","article-title":"EP News: Quality Improvement and Outcomes\u2014The impact of data integrity on improving anticoagulation for patients with atrial fibrillation","volume":"20","author":"Xiang","year":"2023","journal-title":"Heart Rhythm"},{"key":"2026010600351986000_15.1.e003311.24","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026723","article-title":"Trends in Oral Anticoagulant Use Among 436\u2009864 Patients With Atrial Fibrillation in Community Practice, 2011 to 2020","volume":"11","author":"Navar","year":"2022","journal-title":"J Am Heart Assoc"}],"container-title":["BMJ Open Quality"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjoq-2025-003311","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T08:35:29Z","timestamp":1767688529000},"score":1,"resource":{"primary":{"URL":"https:\/\/qir.bmj.com\/lookup\/doi\/10.1136\/bmjoq-2025-003311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,5]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/bmjoq-2025-003311"],"URL":"https:\/\/doi.org\/10.1136\/bmjoq-2025-003311","relation":{},"ISSN":["2399-6641"],"issn-type":[{"value":"2399-6641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}